Health in Hong Kong 404 indicators covering health for Hong Kong. IndicatorLatest Year10-yr change Rank Stomach cancer death rate 4.52 deaths per 100,000 people 2017 down 23.4% 57th Colon and rectum cancer death rate 13.82 deaths per 100,000 people 2017 down 11.2% 18th Breast cancer death rate in women 10.32 deaths per 100,000 people 2017 up 3.6% 86th Cervical cancer death rate in women 2.21 deaths per 100,000 people 2017 down 3.8% 70th Prostate cancer death rate in men 5.62 deaths per 100,000 people 2017 down 4.4% 94th Death rate from cancer by sex 125.97 deaths per 100,000 people 2017 down 19.9% 37th Cardiovascular death rate: crude versus age-standardized 56.16 deaths per 100,000 people 2017 down 37.4% 111th New cases tested for RR-/MDR-TB 96.0% 2024 unchanged 67th Cancer death rates in children under 10 years old 2.66 deaths per 100,000 people 2017 down 35.9% 49th Death rate from cardiovascular diseases by age group 1.36 deaths per 100,000 people 2017 down 36.8% 99th Previously treated cases tested for RR-/MDR-TB 87.0% 2024 up 50.0% 92nd Respiratory infections death rate by age group 1.87 deaths per 100,000 people 2017 down 74.1% 90th Respiratory infection death rate 39.85 deaths per 100,000 people 2017 up 3.4% 33rd Number of people diagnosed with new episode of pulmonary TB who are 471 2021 down 79.0% 90th Number of people diagnosed with new episode of pulmonary TB who have 792 2021 down 2.8% 81st Number of people notified with new episode of TB in a given year 3,735 2021 down 24.2% 83rd Cases started on MDR-TB treatment 19 2024 down 13.6% 106th Number of people diagnosed with new episode of pulmonary TB who are 2,448 2021 up 77.4% 78th Import of environmentally sound technologies 17.76 billion usd 2024 down 42.3% 25th Export of environmentally sound technologies 19.16 billion usd 2024 down 38.3% 18th New or unknown treatment history cases: Pulmonary, bacteriologically 2,090 2023 down 14.3% 92nd Life satisfaction vs. life expectancy 85.51 years 2023 up 2.2% 3rd Tuberculosis patients who tested positive for HIV 30 patients 2021 up 7.1% 102nd Estimated number of MDR/RR-TB incident cases 53 2024 down 33.8% 111th Tuberculosis patients living with HIV receiving antiretroviral therapy 27 patients 2021 up 285.7% 96th HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 up 952.6% 1st Treatment success rate for patients treated for MDR-TB 72.0% 2022 up 14.3% 87th Treatment success rate: HIV-positive TB cases 84 2023 up 35.5% 41st Bladder cancer death rate 1.12 deaths per 100,000 people 2017 down 23.8% 76th Cancer death rates by type 1.12 deaths per 100,000 people 2017 down 23.8% 76th Contraceptive prevalence, any method 66.7% 2017 down 16.1% 30th Liver cancer death rate 10.73 deaths per 100,000 people 2017 down 24.5% 4th Pancreatic cancer death rate 4.71 deaths per 100,000 people 2017 up 13.6% 65th Brain and nervous system cancer death rate 1.02 deaths per 100,000 people 2017 down 15.3% 107th Share of deaths that are registered 96.0% 2019 — 78th Japanese encephalitis - number of reported cases 1 2025 down 50.0% 18th Period versus cohort life expectancy 85.25 years 2023 up 1.9% 1st Annual death rate by age group 1.46 deaths per 1,000 people 2023 down 31.8% 40th Crude death rate 7.35 deaths per 1,000 people 2023 up 21.4% 33rd Birth rate and death rate 7.35 deaths per 1,000 people 2023 up 21.4% 33rd The number of people with susceptibility test result for rifampicin 2,181 2021 — 45th The number of people with susceptibility test result for rifampicin 94.83 2021 — 52nd Annual deaths from all natural disasters 0 people 1983 — 7th Treatment success rate: XDR-TB cases 100 2022 up 100.0% 1st ← Previous Page 7 of 7